Betaloc, or metoprolol tartrate, when used to control the heart rate, a heartbeat of less than 60 beats should be suspended or the dose reduced. When using metoprolol tartrate for the treatment of high blood pressure, it can be continued as long as the patient’s heart rate is greater than 45 beats per minute and the patient has no clinical symptoms.
Metoprolol tartrate belongs to beta-blockers, which can selectively inhibit beta1 receptors, reduce heart rate and blood pressure, and slow down cardiac electrical conduction. Clinically, it is mainly used in the treatment of hypertension and tachyarrhythmia.
The main adverse effects of metoprolol tartrate include fatigue, headache, dizziness, chills in the extremities, bradycardia, palpitations, abdominal pain, nausea, vomiting, diarrhea and constipation.
Contraindications to metoprolol tartrate include cardiogenic shock, hypersensitivity to drug components, sick sinus node syndrome, second and third degree AV block, instability, decompensated heart failure, symptomatic bradycardia or hypotension, heart rate <45 beats/min, heart failure ineffective on digitalis.
When using metoprolol tartrate, patients should always apply under the guidance of a specialist, and adjust the dose in time according to the heart rate and blood pressure levels, and consult a doctor if they feel unwell.